Personal information

Germany

Activities

Works (4)

Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy

Cancers
2023-12 | Journal article | Author
Contributors: Christoph Wetz; Tristan Ruhwedel; Imke Schatka; Jane Grabowski; Henning Jann; Giulia Metzger; Markus Galler; Holger Amthauer; Julian Rogasch
Source: check_circle
Multidisciplinary Digital Publishing Institute

Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [<sup>177</sup>Lu]Lu-DOTATOC

Cancers
2022-03 | Journal article | Author
Contributors: Markus Galler; Julian Rogasch; Kai Huang; Henning Jann; Kristina Plehm; Christoph Wetz; Holger Amthauer
Source: check_circle
Multidisciplinary Digital Publishing Institute

Added Value of Tomoelastography for Characterization of Pancreatic Neuroendocrine Tumor Aggressiveness Based on Stiffness

Cancers
2021-10 | Journal article | Author
Contributors: Emin Gültekin; Christoph Wetz; Jürgen Braun; Dominik Geisel; Christian Furth; Bernd Hamm; Ingolf Sack; Marticorena Garcia SR
Source: check_circle
Multidisciplinary Digital Publishing Institute

The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [<sup>177</sup>Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis

Cancers
2021-02 | Journal article | Author
Contributors: Tristan Ruhwedel; Julian Rogasch; Kai Huang; Henning Jann; Imke Schatka; Christian Furth; Holger Amthauer; Christoph Wetz
Source: check_circle
Multidisciplinary Digital Publishing Institute